flucytosine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Olver, WJ | 1 |
James, SA | 1 |
Lennard, A | 1 |
Galloway, A | 1 |
Roberts, IN | 1 |
Boswell, TC | 1 |
Russell, NH | 1 |
1 other study available for flucytosine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Carrier State; Cross Infectio | 2002 |